CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.42
-2.84 (-5.23%)
At close: Oct 30, 2026, 4:00 PM EDT
51.54
+0.12 (0.23%)
After-hours: Oct 30, 2026, 7:57 PM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or 3.44% compared to the previous year. That makes CRISPR Therapeutics AG the 21,939th largest employer in the world and 2,861st in the United States.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$34,076
Profits / Employee
-$1,147,936
Market Cap
4.97B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
CRSP News
- 11 days ago - Crispr Therapeutics CFO Raju Prasad to step down, A.J. Silver to succeed - TheFly
- 11 days ago - CRISPR Therapeutics Announces Chief Financial Officer Transition - GlobeNewsWire
- 16 days ago - Crispr Therapeutics initiated with a Neutral at UBS - TheFly
- 22 days ago - Crispr Therapeutics price target lowered to $81 from $82 at BofA - TheFly
- 23 days ago - CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026 - GlobeNewsWire
- 4 weeks ago - CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026 - GlobeNewsWire
- 6 weeks ago - CRISPR Therapeutics AG Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire